The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg once-daily in ...

Religious scholars and technologists are asking whether artificial intelligence can reflect the values that shape human life.

A draft blog post left in an unsecured data cache revealed a new model tier called Capybara that Anthropic says is more capable than anything it has built, with the company flagging "unprecedented" ...